Boston Scientific Announces Results for First Quarter 2015
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Boston Scientific (BSX) PT Raised to $21 at Leerink Partners Following Q1
April 29, 2015 8:57 AM EDTLeerink Partners analyst Danielle Antalffy reiterated an Outperform rating and boosted its price target Boston Scientific (NYSE: BSX) price target of $21.00 (from $18.00) following Q1 results and solid 2015 outlook.
Antalffy commented, "Over the last two years, BSX's turnaround story has steadily played out, with new management delivering... More
Boston Scientific (BSX) Reports In-Line Q1 EPS
April 28, 2015 7:01 AM EDTBoston Scientific (NYSE: BSX) reported Q1 EPS of $0.21, in-line with the analyst estimate of $0.21. Revenue for the quarter came in at $1.77 billion versus the consensus estimate of $1.78 billion.
Boston Scientific sees FY2015 EPS of $0.88-$0.92, versus the consensus of $0.91. Boston Scientific sees FY2015 revenue... More
